Major cardiovascular events in patients with severe COPD with and without asthma: a nationwide cohort study

Barbara Bonnesen1, Pradeesh Sivapalan1, Anna Kjær Kristensen1

  • 1Section of Respiratory Medicine, Dept of Medicine, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.

ERJ Open Research
|September 29, 2022
PubMed

Insights

Patients with both chronic obstructive pulmonary disease (COPD) and asthma face a significantly higher risk of cardiovascular events. This comorbidity increases the likelihood of major adverse cardiac events by 20-25%.

Area of Science:

  • Cardiology
  • Pulmonology
  • Epidemiology

Background:

  • Chronic low-grade inflammation, characteristic of asthma, is linked to increased cardiovascular event risk.
  • The study investigates if asthma exacerbates cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).

Purpose of the Study:

  • To evaluate the risk of acute cardiovascular events in patients diagnosed with both COPD and asthma compared to those with COPD alone.

Main Methods:

  • A nationwide, multicenter, retrospective cohort study of Danish outpatients with COPD.
  • Propensity-score matching (1:2 ratio) was used to compare patients with COPD and asthma against those with COPD without asthma.
  • The primary endpoint was severe major adverse cardiac events (MACE), including fatal cardiovascular events and those requiring revascularization or hospitalization.

Main Results:

  • The study included 52,386 Danish patients with COPD; 20.1% had comorbid asthma.
  • Patients with COPD and asthma showed a higher risk of MACE compared to COPD-only patients, with hazard ratios of 1.25 (with pre-existing cardiovascular disease) and 1.22 (without pre-existing cardiovascular disease).
  • This represents an increased risk of 20-25% for MACE in the COPD and asthma group.

Conclusions:

  • Asthma, as a comorbidity in COPD patients, is associated with a substantial increase in cardiovascular event risk.
  • The findings suggest that asthma should be considered a significant risk factor for cardiovascular events in individuals with COPD.
Abstract

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
282
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
463
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K